Alpha-crystallin-derived peptides as therapeutic chaperones
- PMID: 26141743
- PMCID: PMC4673008
- DOI: 10.1016/j.bbagen.2015.06.010
Alpha-crystallin-derived peptides as therapeutic chaperones
Abstract
Background: The demonstration of chaperone-like activity in peptides (mini-chaperones) derived from α-crystallin's chaperone region has generated significant interest in exploring the therapeutic potential of peptide chaperones in diseases of protein aggregation. Recent studies in experimental animals show that mini-chaperones could reach intended targets and alter the disease phenotype. Although mini-chaperones show potential benefits against protein aggregation diseases, they do tend to form aggregates on storage. There is thus a need to fine-tune peptide chaperones to increase their solubility, pharmacokinetics, and biological efficacy.
Scope of review: This review summarizes the properties and the potential therapeutic roles of mini-chaperones in protein aggregation diseases and highlights some of the refinements needed to increase the stability and biological efficacy of mini-chaperones while maintaining or enhancing their chaperone-like activity against precipitation of unfolding proteins.
Major conclusions: Mini-chaperones suppress the aggregation of proteins, block amyloid fibril formation, stabilize mutant proteins, sequester metal ions, and exhibit antiapoptotic properties. Much work must be done to fine-tune mini-chaperones and increase their stability and biological efficacy. Peptide chaperones could have a great therapeutic value in diseases associated with protein aggregation and apoptosis.
General significance: Accumulation of misfolded proteins is a primary cause for many age-related diseases, including cataract, macular degeneration, and various neurological diseases. Stabilization of native proteins is a logical therapeutic approach for such diseases. Mini-chaperones, with their inherent antiaggregation and antiapoptotic properties, may represent an effective therapeutic molecule to prevent the cascade of protein conformational disorders. Future studies will further uncover the therapeutic potential of mini-chaperones. This article is part of a Special Issue entitled Crystallin Biochemistry in Health and Disease.
Keywords: Crystallins; Mini-chaperones; Peptide; Protein aggregation; Therapeutics.
Copyright © 2015. Published by Elsevier B.V.
Figures
Similar articles
-
Therapeutic potential of α-crystallin.Biochim Biophys Acta. 2016 Jan;1860(1 Pt B):252-7. doi: 10.1016/j.bbagen.2015.03.012. Epub 2015 Apr 1. Biochim Biophys Acta. 2016. PMID: 25840354 Free PMC article. Review.
-
Alpha crystallins in the retinal pigment epithelium and implications for the pathogenesis and treatment of age-related macular degeneration.Biochim Biophys Acta. 2016 Jan;1860(1 Pt B):258-68. doi: 10.1016/j.bbagen.2015.05.016. Epub 2015 May 27. Biochim Biophys Acta. 2016. PMID: 26026469 Free PMC article. Review.
-
Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.Acc Chem Res. 2018 Mar 20;51(3):745-752. doi: 10.1021/acs.accounts.7b00250. Epub 2018 Feb 14. Acc Chem Res. 2018. PMID: 29442498 Review.
-
Role of crystallins in diabetic complications.Biochim Biophys Acta. 2016 Jan;1860(1 Pt B):269-77. doi: 10.1016/j.bbagen.2015.05.009. Epub 2015 May 17. Biochim Biophys Acta. 2016. PMID: 25988654 Review.
-
Interaction of α-crystallin with some small molecules and its effect on its structure and function.Biochim Biophys Acta. 2016 Jan;1860(1 Pt B):211-21. doi: 10.1016/j.bbagen.2015.06.002. Epub 2015 Jun 12. Biochim Biophys Acta. 2016. PMID: 26073614 Review.
Cited by
-
Isomerization of Asp is essential for assembly of amyloid-like fibrils of αA-crystallin-derived peptide.PLoS One. 2021 Apr 15;16(4):e0250277. doi: 10.1371/journal.pone.0250277. eCollection 2021. PLoS One. 2021. PMID: 33857260 Free PMC article.
-
Peptide-Based Molecular Strategies To Interfere with Protein Misfolding, Aggregation, and Cell Degeneration.Angew Chem Int Ed Engl. 2020 Feb 24;59(9):3372-3384. doi: 10.1002/anie.201906908. Epub 2019 Nov 28. Angew Chem Int Ed Engl. 2020. PMID: 31529602 Free PMC article. Review.
-
Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review).Mol Med Rep. 2025 Jan;31(1):22. doi: 10.3892/mmr.2024.13387. Epub 2024 Nov 8. Mol Med Rep. 2025. PMID: 39513587 Free PMC article. Review.
-
Small Heat Shock Proteins in Retinal Diseases.Front Mol Biosci. 2022 Apr 11;9:860375. doi: 10.3389/fmolb.2022.860375. eCollection 2022. Front Mol Biosci. 2022. PMID: 35480891 Free PMC article. Review.
-
A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments.Nat Commun. 2022 Aug 8;13(1):4614. doi: 10.1038/s41467-022-32423-9. Nat Commun. 2022. PMID: 35941164 Free PMC article.
References
-
- Bloemendal H. Molecular and Cellular Biology of the Eye Lens. John Willey & Sons; New York: 1981. The lens proteins; pp. 1–49.
-
- Horwitz J. Alpha-crystallin. Exp Eye Res. 2003;76:145–153. - PubMed
-
- Bloemendal H, de Jong W, Jaenicke R, Lubsen NH, Slingsby C, Tardieu A. Ageing and vision: structure, stability and function of lens crystallins. Prog Biophys Mol Biol. 2004;86:407–485. - PubMed
-
- Horwitz J, Huang QL, Ding L, Bova MP. Lens alpha-crystallin: chaperone-like properties. Methods Enzymol. 1998;290:365–383. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials